<DOC>
	<DOCNO>NCT01577407</DOCNO>
	<brief_summary>The purpose protocol test effect non opioid nefopam experimental dyspnea counterirritation ( ie inhibition one pain another pain ) induce dyspnea healthy subject .</brief_summary>
	<brief_title>Non Opioid Treatment Experimental Dyspnea</brief_title>
	<detailed_description>Dyspnea pain share many feature . One counterirritation phenomenon : define pain research attenuation one pain another pain . Dyspnea induce inspiratory threshold loading ( increase sense work/effort ) show attenuate electrical pain show nociceptive flexion reflex inhibition , thermal pain , measure cortical evoked response ( laser evoke potentials-LEP ) . The investigator study whether nefopam modulates counterirritation laboratory induce dyspnea healthy subject . The effect nefopam experimental dyspnea measure visual analog scale ( VAS ) validate multidimensional dyspnea profile ( MDP ) . The effect treatment counterirritation measure record LEP obtain use CO2 laser system . The amplitude N2-P2 component LEP main study outcome .</detailed_description>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Nefopam</mesh_term>
	<mesh_term>Analgesics , Non-Narcotic</mesh_term>
	<criteria>Healthy Nonsmoking acute chronic pain antalgic psychoactive drug use nefopam hypersensibility severe allergy diabetes glaucoma prostate adenoma seizure disorder convulsion history heart circulation disease pulmonary disease asthma kidney liver disease brain nerve disease lack adhesion antalgic drug , alcohol , coffee cola within previous experiment day consumption</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Dyspnea</keyword>
	<keyword>Pain</keyword>
</DOC>